Pyxis Oncology, Inc. PYXS
NASDAQ · United States · Health Technology
$2.15-0.04 (-2.05%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.40 | -0.35 | -14.3% | $0 | -100.0% | -5.3%$3.18→$3.01 |
| Q1 2026 | 2026-05-14 | -0.37 | -0.35 | -5.7% | — | — | -13.0%$2.62→$2.28 |
| Q4 2025 | 2026-03-23 | -0.29 | -0.34 | +14.7% | — | — | -7.5%$1.47→$1.36 |
| Q3 2025 | 2025-11-03 | -0.35 | -0.34 | -2.9% | — | — | +9.6%$3.56→$3.90 |
| Q2 2025 | 2025-08-14 | -0.30 | -0.35 | +14.3% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.35 | -0.30 | -16.7% | — | — | — |
| Q4 2024 | 2025-03-18 | -0.26 | -0.33 | +21.2% | — | — | — |
| Q2 2024 | 2024-08-14 | -0.29 | -0.33 | +12.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.